Therapy of gastric mucosa associated lymphoid tissue lymphoma

doi:10.3748/wjg.v13.i26.3554

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3001)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

360

HTML

2086

Figures (1-1)

357

Tables (1-1)

198

Sum=3001

Jul 14, 2007 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 14, 2007; 13(26): 3554-3566
Published online Jul 14, 2007. doi: 10.3748/wjg.v13.i26.3554

Therapy of gastric mucosa associated lymphoid tissue lymphoma

Andrea Morgner, Renate Schmelz, Christian Thiede, Manfred Stolte, Stephan Miehlke

Andrea Morgner, Renate Schmelz, Christian Thiede, Stephan Miehlke, Medical DepartmentI, University Hospital, Technical University Dresden, Germany

Manfred Stolte, Institute for Pathology, Academic Teaching Hospital Bayreuth, Bayreuth, Germany

Author contributions: All authors contributed equally to the work.

Correspondence to: Andrea Morgner-Miehlke, MD, Associate Professor, Medical DepartmentI, Gastroenterology, University Hospital Carl Gustav Carus, Fetscherstrasse 74, Dresden 01307, Germany. andrea.morgner-miehlke@uniklinikum-dresden.de

Telephone: +49-351-4584194 Fax: +49-351-4584394

Received: April 2, 2007
Revised: April 3, 2007
Accepted: April 26, 2007
Published online: July 14, 2007

Abstract

Gastric mucosa associated lymphoid tissue (MALT) lymphoma has recently been incorporated into the World Health Organization (WHO) lymphoma classification, termed as extranodal marginal zone B-cell lymphoma of MALT-type. In about 90% of cases this lymphoma is associated with H pylori infection which has been clearly shown to play a causative role in lymphomagenesis. Although much knowledge has been gained in defining the clinical features, natural history, pathology, and molecular genetics of the disease in the last decade, the optimal treatment approach for gastric MALT lymphomas, especially locally advanced cases, is still evolving. In this review we focus on data for the therapeutic, stage dependent management of gastric MALT lymphoma. Hence, the role of eradication therapy, surgery, chemotherapy and radiotherapy is critically analyzed. Based on these data, we suggest a therapeutic algorithm that might help to better stratify patients for optimal treatment success.

Keywords: Gastric lymphoma; Mucosa-associated lymphoid tissue; H pylori; Eradication; Radiation; Surgery; Chemotherapy; Molecular genetics